...
首页> 外文期刊>International Journal of Pharmaceutical Sciences Review and Research >Assessment of Prescribing Patterns and Health-Related Quality of Life in Cerebral Stroke Patients
【24h】

Assessment of Prescribing Patterns and Health-Related Quality of Life in Cerebral Stroke Patients

机译:在脑卒中患者中评估规定模式和与健康有关的生活质量

获取原文

摘要

Background and Stroke was one of the major public health challenges, not only for neuroscience but the society in general. This study aimed to assess the Prescribing Patterns and Health-Related Quality of Life in Cerebral Stroke patients. Methods: This is a prospective observational study for 6 months where patients diagnosed with cerebral stroke, satisfying the inclusion criteria were recruited and were categorized into Ischemic and hemorrhagic stroke. A standardised data collection was prepared and symptoms, risk factors and the prescription pattern of various drugs used were recorded. Quality of Life assessment was done by the Short Form-36 questionnaire and paired t-test was used for determining any significance in the change detected before and after treatment. Results: Out of 150 patients’ stroke was higher in males (63%). The weakness of limbs (32%) constitutes the major complaint. Major risk factors associated were hypertension (30%), diabetes mellitus (18%). Cognitive enhancers (16%), antiplatelets (14%) were the most prescribed class of drugs and in combination aspirin + clopidogrel was highly prescribed. The response score of all scales increased statistically (p-value < 0.0001) indicating improved Quality of life after treatment. Conclusion: Long term studies are further required to evaluate the benefit of combinational therapy over monotherapy and to develop standard guidelines for better management. Integration of the role of a pharmacist in the management of the disease is crucial and improves clinical outcomes of patients.
机译:背景和中风是主要的公共卫生挑战之一,不仅适用于神经科学,而是整体社会。本研究旨在评估脑卒中患者的处方模式和与健康相关的生活质量。方法:这是6个月的前瞻性观察研究,其中招募了患有脑卒中的患者,满足纳入标准,并分为缺血性和出血性脑卒中。编写了标准化的数据收集,并记录了所用药物的症状,危险因素和处方模式。寿命评估的质量由短型-36调查问卷和配对的T检验用于确定治疗前后检测到的变化中的任何重要性。结果:150名患者中风中的血液中较高(63%)。四肢的弱点(32%)构成了主要投诉。相关的主要危险因素是高血压(30%),糖尿病(18%)。认知增强剂(16%),抗血浆(14%)是最规定的药物,并且在阿司匹林+氯吡格雷的组合中高度规定。所有尺度的响应得分增加了统计上(p值<0.0001),表明治疗后的寿命质量提高。结论:进一步要求长期研究评估组合治疗对单一疗法的益处,并制定用于更好管理的标准指南。一体化药剂师在疾病管理中的作用至关重要,提高了患者的临床结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号